Beginning in the mid-forties, men may also experience a range of general symptoms, including hot flashes, sleep disturbances, fatigue, nervousness, and depressed mood. Libido and sexual activity decline with age: compared with men at age 30, sexual activity decreases by approximately 50% by age 50 and to about 20% by age 75. Testosterone deficiency also leads to loss of muscle mass, reduced bone mineral density, and decreased physical performance. The scientifically preferred terms for this condition are age-related hypogonadism or PADAM (Partial Androgen Deficiency of the Aging Male).
Terminology Used for Age-Related Testosterone Deficiency
Several terms are used to describe age-related testosterone deficiency:
Hormonal Changes in Men Occur Gradually
Average testosterone blood levels decline slowly between the ages of 40 and 70:
As a result, biologically active testosterone declines by about 30% over this period. (Massachusetts Male Aging Study, Gray et al., 1991).
Typical Symptoms of Testosterone Deficiency
Common clinical symptoms include:
Musculoskeletal Symptoms
Psychological and Cognitive Symptoms
Sexual Symptoms
Low testosterone may contribute to erectile dysfunction in approximately 20% of affected men and may be the sole cause in about 3% of cases.
Blood-Related Symptoms
Diagnosis of Testosterone Deficiency
According to a consensus statement from German professional societies in andrology, dermatology, endocrinology, and urology, treatment-requiring testosterone deficiency is diagnosed when:
Symptoms Considered in Diagnosis
Testosterone Replacement Therapy (TRT)
When testosterone deficiency (hypogonadism) has been confirmed through both symptoms and laboratory testing, testosterone replacement therapy (TRT) may be considered. The goal of treatment is to restore testosterone levels to the normal physiological range and improve symptoms such as reduced libido, erectile dysfunction, fatigue, depressed mood, loss of muscle mass, and reduced bone density.
Several formulations are available, including injections, topical gels, oral capsules (in some countries), and long-acting implants.
Injectable Testosterone Preparations
Injectable testosterone remains one of the most commonly prescribed forms of TRT because of its effectiveness and relatively low cost.
Short-Acting Injections
Generic Name | Europe | United States | India | Typical Dosing |
Testosterone Enanthate | Testoviron® Depot | Delatestryl® (limited availability), Generic Testosterone Enanthate | Testoviron® Depot | Every 2–3 weeks |
Testosterone Cypionate | Limited availability | Depo-Testosterone® | Available through some manufacturers | Every 1–2 weeks |
Characteristics
Advantages
Disadvantages
Long-Acting Injections
Generic Name | Europe | United States | India | Typical Dosing |
Testosterone Undecanoate | Nebido® | Aveed® | Nebido® | Every 10–14 weeks |
Characteristics
Advantages
Disadvantages
Long-acting testosterone undecanoate is often considered the preferred injectable option for long-term treatment because it more closely mimics physiological testosterone levels.
Testosterone Gels
Testosterone gels are applied once daily and provide relatively stable hormone levels.
Common Gel Preparations
Generic Name | Europe | United States | India |
Testosterone Gel | Testogel®, Tostran®, Androgel® | AndroGel®, Testim®, Vogelxo®, Fortesta® | Testogel®, AndroGel®, Tostran® |
Testosterone Solution | Axiron® | Axiron® | Limited availability |
Application Sites
Product | Application Area |
Testogel®, AndroGel®, Testim® | Upper arms, shoulders, abdomen |
Tostran® | Abdomen and thighs |
Axiron® | Armpits (axillary application) |
Advantages
Disadvantages
Important Safety Measures
After applying testosterone gel:
Oral Testosterone
Oral testosterone formulations are available in some countries.
Generic Name | Europe | United States | India |
Testosterone Undecanoate Capsules | Andriol® Testocaps | Jatenzo®, Tlando®, Kyzatrex® | Andriol® |
Advantages
Disadvantages
Testosterone Pellets (Implants)
Small testosterone pellets can be implanted under the skin and provide long-term hormone replacement.
Generic Name | Europe | United States | India |
Testosterone Pellets | Limited use | Testopel® | Rarely available |
Characteristics
Comparison of Testosterone Formulations
Formulation | Dosing Frequency | Hormone Stability | Convenience | Cost |
Enanthate/Cypionate Injection | Every 1–3 weeks | Moderate | Moderate | Low |
Undecanoate Injection (Nebido/Aveed) | Every 10–14 weeks | Excellent | Excellent | High |
Testosterone Gel | Daily | Excellent | Good | Moderate–High |
Oral Testosterone | Daily | Good | Excellent | High |
Testosterone Pellets | Every 3–6 months | Excellent | Excellent | High |
Choosing the Right Therapy
The optimal testosterone formulation depends on:
Typical Clinical Preference
Situation | Commonly Preferred Option |
Lowest cost | Testosterone Enanthate or Cypionate |
Most stable long-term levels | Testosterone Undecanoate (Nebido®/Aveed®) |
Avoid injections | Testosterone Gel |
Maximum convenience | Long-acting Undecanoate or Pellets |
Easy dose adjustment | Testosterone Gel |
For many men with diabetes and age-related hypogonadism, long-acting testosterone undecanoate (Nebido®/Aveed®) or daily testosterone gel are often considered the most physiologic and convenient treatment options because they provide relatively stable testosterone levels with fewer hormonal fluctuations.
by clothing.
Monitoring During Testosterone Therapy
Regular monitoring is essential during testosterone replacement therapy.
Initially Every Three Months, Later Every Six Months
Additional Monitoring
These tests are generally recommended every six months.
Possible Side Effects of Testosterone Therapy
Although testosterone therapy is generally considered safe, several important risks must be considered.
Prostate
Testosterone can accelerate the growth of an existing prostate cancer. Therefore:
However, current evidence indicates that testosterone replacement itself does not increase the risk of developing a new prostate cancer.
Breast Enlargement
Sleep Apnea
Polycythemia
Testosterone Deficiency and Diabetes
Men with Type 2 diabetes frequently have low testosterone levels.
Normally, low testosterone should trigger the hypothalamus and pituitary gland to increase the production of GnRH, LH, and FSH, thereby stimulating testosterone production. However, many men with Type 2 diabetes are also obese. In obesity, LH and FSH levels often remain low despite low testosterone levels. As a result, the testes receive insufficient stimulation to produce testosterone.
This can create a vicious cycle:
Research Findings on Testosterone Therapy
An English study compared:
After eight years:
The study concluded that testosterone therapy had a positive effect on several components of metabolic syndrome in hypogonadal men with Type 2 diabetes.